Abbott | Kortsiktig Gjeld



Current Liabilities Endring Dato
Abbott USD 13B 1.15B 2025-03
Agilent USD 1.87B 26M 2025-01
AtriCure USD 61.22M 12.2M 2025-03
Baxter International USD 6.51B 311M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Danaher USD 6.64B 153M 2025-03
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Hologic USD 1B 34.8M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.01B 200.9M 2025-03
J&J USD 56.9B 6.58B 2025-03
Masimo USD 617.7M 19.9M 2024-12
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 196.82M 19.58M 2025-03
Pfizer USD 43B 216M 2024-12
Smith & Nephew USD 1.53B 246M 2024-12
Solventum Corp 2.7B 201M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teleflex USD 675.91M 26.55M 2025-03
Terumo JPY 263.85B 32.8B 2024-12
Thermo Fisher Scientific USD 13.17B 158M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Abbott Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.